2023 DMEC Virtual Annual Conference: Coming Soon? Regulated Psychedelics for Mental Health & What You Need to Know


Back to Package

Psychedelic medicine innovations are all over the media, and the Federal Drug Administration is expected to approve psychedelic therapies for PTSD treatment in 2023 or 2024. Based on the strength of treatment success for ketamine-assisted psychotherapy, some states have begun developing regulations and guidelines. In this session, we’ll review an evidence-based perspective on emerging treatment options and discuss the opportunities and barriers to approving and paying for this treatment for PTSD and other work-related mental health disorders.

Speaker:
Michael M. Coupland, RPsych, VP, Occupational Health, Stella

Key:

Complete
Failed
Available
Locked
Webinar Recording
Open to view video.
Open to view video.
You must register to access.
Webinar Recording (with captions)
Open to view video.
Open to view video.
You must register to access.
Certificate of Attendance
Open to download resource.
Open to download resource.
You must register to access.
Certificate of Attendance (for captioned recording).
Open to download resource.
Open to download resource.
You must register to access.
CLMS CEU Code
Enter code to continue.
Enter code to continue.
You must register to access.
Event Qualifies for the Following CEUs
1.00 CLMS CEU credit  |  No certificate available
1.00 CLMS CEU credit  |  No certificate available
You must register to access.